Hologic
Hologic guides low for 2013, expecting $25M impact of the device tax
Breast cancer: FDA panel votes to expand PMA for Hologic’s mammography system
Hologic’s Gen-Probe subsidiary notches legal win over Becton, Dickinson
Teleflex expands catheter OEM business | Wall Street Beat
Layoffs: Medical device companies cut 2,000 jobs in 2 months
Medical device companies are molting at a reptilian rate, shedding more than 2,000 jobs over the past 2 months as they look to slash costs across the board.
Several of the med-tech companies that are scrapping jobs say the 2.3% medical device excise tax in the Patient Protection and Affordable Care Act, slated to begin in January 2013. Others deny that the tax is the sole cause of their moves, saying it’s a factor but not determinative.
Hologic loses $4M patent suit to Smith & Nephew over Interlace fibroid tech
FDA to review expanded approval for Hologic’s breast cancer imaging systems
Massachusetts-based women’s health devices maker Hologic (NSDQ:HOLX) has got a date with the FDA.
Later this year the federal watchdog agency’s Radiological Devices Panel will meet in Washington D.C. to discuss expanding approval for Hologic’s 1st-of-its-kind Selenia Dimensions 3D digital mammography system.